Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Boehringer Ingelheim
Baxter
Moodys
Medtronic

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VELTASSA

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for Veltassa

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00868439 Evaluation of Patiromer in Heart Failure Patients Completed Medpace, Inc. Phase 2 2009-04-01 The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.
NCT00868439 Evaluation of Patiromer in Heart Failure Patients Completed Relypsa, Inc. Phase 2 2009-04-01 The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.
NCT01130597 Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease Completed Relypsa, Inc. Phase 2 2010-05-01 The purpose of this study was to evaluate the feasibility of individualized titration of patiromer according to serum potassium. This study also assessed the safety and tolerability of patiromer and the effects of patiromer on serum potassium in heart failure (HF) participants with chronic kidney disease (CKD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Veltassa

Condition Name

Condition Name for Veltassa
Intervention Trials
Hyperkalemia 9
Heart Failure 2
Hypertension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Veltassa
Intervention Trials
Hyperkalemia 10
Renal Insufficiency, Chronic 6
Kidney Diseases 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Veltassa

Trials by Country

Trials by Country for Veltassa
Location Trials
United States 49
Georgia 6
Ukraine 4
Hungary 3
Germany 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Veltassa
Location Trials
Texas 5
Florida 5
California 4
New York 4
Illinois 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Veltassa

Clinical Trial Phase

Clinical Trial Phase for Veltassa
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Veltassa
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 3
Recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Veltassa

Sponsor Name

Sponsor Name for Veltassa
Sponsor Trials
Relypsa, Inc. 10
Medpace, Inc. 1
NHS Greater Glasgow and Clyde 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Veltassa
Sponsor Trials
Industry 12
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Mallinckrodt
Dow
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.